NCT06999473Not yet recruiting
Assessment and Treat Neglect Patients With a VR Application
Assess and Treat Visuospatial Neglect in Central Neurological Conditions Via an Innovative Virtual Reality Software
Source: ClinicalTrials.gov · Last updated 31 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of this project is to investigate the effectiveness of neglect training in our self-developed VR application "SpatialSense". The investigators aim to reach the following goals: i. Compare conventional neglect therapy for neglect training with SpatialSense to evaluate the impacts on neglect recovery to see whether the VR therapy improves the clinical outcomes, such as balance recovery, perception of verticality, quality of life, independence in daily activities, and cognitive impairment, after rehabilitation training. ii. Analyze and compare the search strategies employed by stroke patients with VSN and those without VSN during the execution of the search task with SpatialSense to summarize typical visual scanning strategies for facilitation, rehabilitation training, and improving the transfer effect in daily activities. The experimental group will receive both conventional OT and PT treatment, but 3 days a week, half an hour of conventional treatment will be replaced by treatment with SpatialSense software. The control group will receive their regular dose-matched conventional OT and PT sessions without interference. The experimental group will receive SpatialSense training 3 times a week for a consecutive 4 weeks (12 sessions in total of 30 minutes).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 27 Apr 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 May 2027
- Lead sponsor
- Universiteit Antwerpen
- Diseases
- Stroke
- NCT number
- NCT06999473
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Jun 2025 to the primary completion date, 1 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have a medical implant, such as a cochlear implant or a pacemaker
Other illness
- Have a severe comorbid psychiatric (E.g. psychotic symptoms) disorder
- Have a premorbid neurodegenerative disease (E.g. Alzheimer's dementia, vascular dementia)
- Have a severe visual impairment that cannot be corrected by wearing glasses while training
- Have a history of epileptic seizures The following exclusion criteria do not apply to the Non-VSN stroke group.
Other
- Have severe written language comprehension deficits
- Do not show signs of a spatial asymmetry in performance on a battery of screening tasks
- Having visual field deficits or lesions in the occipital lobe
Who the study is looking for
- Age 18 years or older
- Able to provide informed consent
- have had a hemispheric stroke
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp Coordinator of this site? Confirm its status | Antwerp | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.